LYB
22
2
LB
71
5
MKC
59
3
PLD
46
6
CMA
64
2
COST
50
2
CCI
21
-7
NEE
70
2
ILMN
52
3
EXR
62
7
UA
48
-8
LLY
53
6
ALL
56
3
GWW
69
2
LRCX
64
-7
SEE
63
2
CAT
53
3
XYL
68
2
MRK
40
5
TDC
67
-3
LYB
22
2
LB
71
5
MKC
59
3
PLD
46
6
CMA
64
2
COST
50
2
CCI
21
-7
NEE
70
2
ILMN
52
3
EXR
62
7
UA
48
-8
LLY
53
6
ALL
56
3
GWW
69
2
LRCX
64
-7
SEE
63
2
CAT
53
3
XYL
68
2
MRK
40
5
TDC
67
-3
Financhill
Back

Altimmune Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47

ALT
Altimmune

Last Price:
$5.51
Seasonality Move:
24.6%

7 Day Trial

ALL ACCESS PASS

$ 7

Altimmune Stock Forecast

  • Over the next 52 weeks, Altimmune has on average historically risen by 2% based on the past 19 years of stock performance.
  • Altimmune has risen higher in 7 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.84%
  • Is Altimmune Stock Undervalued?
    The current Altimmune [ALT] share price is $5.58. The Score for ALT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • ALT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Altimmune Stock Go Up Next Year?

  • Over the next 52 weeks, Altimmune has on average historically risen by 2% based on the past 19 years of stock performance.

Altimmune Stock Rating

Sell
47
Altimmune (ALT) is a Sell

Is Altimmune overpriced?

  • Altimmune has risen higher in 7 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.84%

Altimmune Stock Price History

Is ALT stock going to rise?

  • The current trend is moderately bullish and ALT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
altimmune.com

52-Week Data

52-Week High:
11.16
52-Week Low:
3.55

Prediction Charts

Market Cap:
429.7M
Price in USD:
5.58
Volume:
2.1M
Beta:
1.20

Technical Analysis

SMA50:
5.19
SMA100:
6.02
SMA200:
6.61
52-Wk Change:
-37.3%

Stock Predictions

  • Is Altimmune stock public?
    Yes, Altimmune is a publicly traded company.
  • What is the Altimmune stock quote today?
    The Altimmune stock price is 5.58 USD today.
  • How to buy Altimmune stock online?
    You can buy Altimmune shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-29 5.05 5.10 5.21 4.95
Apr-30 5.01 5.25 5.30 4.98
May-1 5.25 5.17 5.37 5.07
May-2 5.27 5.77 6.05 5.26
May-5 5.68 5.43 5.76 5.39
May-6 5.36 5.03 5.37 4.95
May-7 5.18 5.36 5.36 5.07
May-8 5.50 5.80 5.90 5.25
May-9 5.88 5.59 6.05 5.52
May-12 5.80 6.01 6.07 5.80
May-13 6.07 5.76 6.13 5.49
May-14 5.79 5.70 5.89 5.60
May-15 5.75 5.78 5.85 5.60
May-16 5.80 5.58 5.88 5.51

Altimmune Earnings

Altimmune Earnings Report: Per Share Altimmune Earnings Q1 Q2 Q3 and Q4 last year and next year.

Altimmune Forecast Revenue Growth

Altimmune Stock Analysis: Historical quarterly revenues per share for Altimmune and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.10 per share, and a decrease next year of $0.18 per share.

* Altimmune stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.